{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:06:23Z","timestamp":1791288383063,"version":"4.3.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2025,6,17]]},"abstract":"<jats:sec xml:lang=\"en\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p xml:lang=\"en\">Failure to control blood pressure (BP) despite multiple prescribed antihypertensive medications (AHMs) is widespread and leads to worse clinical outcomes. Recent changes to BP targets in US clinical guidelines require an updated evaluation of BP control including evaluations of nonadherence and therapeutic inertia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p xml:lang=\"en\">We leveraged clinical and insurance data sourced from &gt;50 US health care organizations to identify &gt;500\u2009000 patients with established hypertension (&gt;15\u2010month history) concurrently prescribed \u22653 AHM classes in 2019. We characterized the prevalence of uncontrolled hypertension and describe patterns of nonadherence (lack of AHM fills covering &gt;80% of days) and therapeutic inertia (failure to escalate AHM for patients persistently out of BP control). We described the associations with factors including race, ethnicity, sex, and insurance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p xml:lang=\"en\">Among 565\u2009737 patients prescribed \u22653 AHMs, 37.7% met the recommended BP target of &lt;130\/80\u2009mm\u2009Hg. Black race (odds ratio [OR], 0.71 [95% CI, 0.70\u20130.73]) and uninsured status (OR, 0.81 [95% CI, 0.76\u20130.86]) were most associated with lack of BP control relative to White or commercially insured patients. In a subset of insured patients, nonadherence occurred in 52.7%, although BP control remained poor among adherent patients (43.0% versus 39.4% for nonadherent). Therapeutic inertia was widespread; 64.5% of patients persistently above the BP target had no medication escalation within 18 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p xml:lang=\"en\">An evaluation of a US\u2010based, large, real\u2010world patient cohort demonstrates that most patients prescribed \u22653 AHMs fail to achieve the recommended BP target of &lt;130\/80, and both medication nonadherence and therapeutic inertia are widespread.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/jaha.124.034787","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:19:42Z","timestamp":1750054782000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of Blood Pressure Control, Medication Adherence, and Therapeutic Inertia in US Patients With Hypertension Prescribed Multiple Antihypertensives"],"prefix":"10.1161","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-9223","authenticated-orcid":false,"given":"Jeff T.","family":"Mohl","sequence":"first","affiliation":[{"name":"AMGA (American Medical Group Association)","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1237-0645","authenticated-orcid":false,"given":"Carlos A.","family":"Moreno","sequence":"additional","affiliation":[{"name":"AMGA (American Medical Group Association)","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Sadik","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC","place":["Titusville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6986-6887","authenticated-orcid":false,"given":"Mukul","family":"Singhal","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC","place":["Titusville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2731-4944","authenticated-orcid":false,"given":"Alicia","family":"Rooney","sequence":"additional","affiliation":[{"name":"AMGA (American Medical Group Association)","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-7946","authenticated-orcid":false,"given":"Elizabeth L.","family":"Ciemins","sequence":"additional","affiliation":[{"name":"AMGA (American Medical Group Association)","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13364"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.123.20894"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2147\/IBPC.S223334"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLINTHERA.2009.05.007"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000084"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.068064"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2017.11.006"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.005979"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJCHY.2020.100061"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92143-w"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.12.033"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-022-01173-w"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002184"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021640"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.08028.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011121"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.3.600"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000421"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/AJE\/KWQ433"},{"key":"e_1_3_2_21_2","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry NK","year":"2009","unstructured":"Choudhry NK, Shrank WH, Levin RL, Lee JL, Jan SA, Brookhart MA, Solomon DH. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009;15:457.","journal-title":"Am J Manag Care"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903126833"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.00687"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1829-z"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.217"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.4710290119"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.161950"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2019.100850"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020997"},{"key":"e_1_3_2_30_2","first-page":"722A","article-title":"Blood pressure targets in adults with hypertension: a clinical practice guideline from the AAFP","volume":"106","author":"Coles S","year":"2022","unstructured":"Coles S, Fisher L, Lin KW, Lyon C, Vosooney AA, Bird MD. Blood pressure targets in adults with hypertension: a clinical practice guideline from the AAFP. Am Fam Physician. 2022;106:722A\u2013722K.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43001"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.124.034787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:36:35Z","timestamp":1756359395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.124.034787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6,17]]}},"alternative-id":["10.1161\/JAHA.124.034787"],"URL":"https:\/\/doi.org\/10.1161\/jaha.124.034787","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"2024-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e034787"}}